AcquirerTargetPrice
Baxalta Inc. Collaboration on CAR T cell therapies$105 million
ResMed Inc. Brightree$800 million
AmgenRights to wearable drug injectors$55 million
Recipharm ABMitim Srl$74.7 million
McKesson Corporation2 oncology companies$1.2 billion